TY  - JOUR
T1  - COVID-19 Vaccine Literacy in Cancer Patients and their Attitudes towards COVID-19 Vaccination
TT  - Kanser Hastalarında COVID-19 Aşı Okuryazarlığı ve Kanser Hastalarının COVID-19 Aşısına Yönelik Tutumları
AU  - Ataoğlu, Beyza Nur
AU  - Save, Dilşad
AU  - Domruk, Ömer Faruk
AU  - Alan, Oğulcan
AU  - Domruk, Yusra
AU  - Hıdıroğlu, Seyhan
PY  - 2025
DA  - June
Y2  - 2025
JF  - Türkiye Biyoetik Dergisi
JO  - TJOB
PB  - Türkiye Biyoetik Derneği
WT  - DergiPark
SN  - 2148-5917
SP  - 89
EP  - 106
VL  - 12
IS  - 2
LA  - en
AB  - Background: Determining the motivations behind receiving the COVID-19 vaccination is essential for providing equitable and ethical care. The aim of this study is to assess the COVID-19 vaccine literacy and attitude towards the COVID-19 vaccine among cancer patients, with a focus on identifying disparities that may inform ethical healthcare practices. Method: This cross-sectional study included patients aged 18 and above who were receiving a treatment for at least one malignancy at a training and research hospital in October of 2022. A total of 198 patients were assessed using the COVID-19 Vaccine Attitudes Scale and the COVID-19 Vaccine Literacy Scale. Results: While every patient had a history of at least one cancer, 88.4% (n=175) of them had at least one COVID-19 vaccine. Patients who were male or older than 60 years old had more positive attitudes about vaccination (p=0.020; p
KW  - vaccination
KW  - Medical Ethics
KW  - COVID 19
N2  - Giriş: COVID-19 aşısını olma motivasyonlarının belirlenmesi, adil ve etik sağlık hizmeti sunumu açısından oldukça önemlidir. Bu çalışmanın amacı, kanser hastalarında COVID-19 aşı okuryazarlığını ve COVID-19 aşısına yönelik tutumu değerlendirmek olup, etik sağlık uygulamalarını yönlendirebilecek olası eşitsizlikleri ortaya koymaya odaklanmaktır.  Yöntem: Bu kesitsel çalışmaya, Ekim 2022’de bir eğitim ve araştırma hastanesinde en az bir malignite (kanser) nedeniyle tedavi gören, 18 yaş ve üzeri hastalar dâhil edilmiştir. Toplam 198 hasta, COVID-19 Aşı Tutum Ölçeği ve COVID-19 Aşı Okuryazarlığı Ölçeği kullanılarak değerlendirilmiştir.Bulgular: Her hastanın en az bir kanser öyküsü olmasına rağmen, bunların %88,4'ü (n=175) en az bir COVID-19 aşısı yaptırdı. Erkek veya 60 yaşından büyük olan hastaların aşıya yönelik tutumları daha olumluydu (p=0,020; p
CR  - Sinha S, Kundu CN. Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? Medical Oncology, 2021;38(9):1-7.
CR  - WHO. Situation Report-51 Situation in Numbers total and new cases in last 24 hours. https://iris.who.int/handle/10665/331475  [cited 2024 November 1].
CR  - Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and cancer: Lessons from a pooled meta-analysis. JCO Glob Oncol, 2020 Nov;6(6):557-9.
CR  - Wang L, Sun Y, Yuan Y, Mei Q, Yuan X. Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities. Aging. 2020;12(23):24462-74.
CR  - Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol, 2020;21(3):335-7.
CR  - Wu MY, Li CJ, Yiang GT, Cheng YL, Tsai APY, Hou YT, et al. Molecular Regulation of bone metastasis pathogenesis. Cell Physiol Biochem. 2018;46(4):1423-38.
CR  - Kang DH, Weaver MT, Park NJ, Smith B, McArdle T, Carpenter J. Significant impairment in immune recovery after cancer treatment. Nurs Res, 2009;58(2):105-14.
CR  - Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov, 2020;10(6):783.
CR  - Tsai R, Hervey J, Hoffman K, Wood J, Johnson J, Deighton D, Clermont D, Loew B, Goldberg SL. COVID-19 vaccine hesitancy and acceptance among individuals with cancer, autoimmune diseases, or other serious comorbid conditions: Cross-sectional, internet-based survey. JMIR Public Health Surveill, 2022;8(1):e29872.
CR  - Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine, 2020;383(27):2603-15.
CR  - Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine, 2021;384(5):403-16.
CR  - Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, et al. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis. Eur J Cancer, 2022;160:243-260.
CR  - CDC. Clinical Guidance for COVID-19 Vaccination. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#contraindications [cited 2024 January 15].
CR  - CDC. COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html [cited 2024 January 15].
CR  - Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C. Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 2016;14(7):882-913.
CR  - ESMO. COVID-19 vaccination. https://www.esmo.org/covid-19-and-cancer/covid-19-vaccination [cited 2024 November 1].
CR  - Cancer. Turkish Society of Medical Oncology COVID-19 Pandemic Advisory Board Vaccination Recommendations for Cancer Patients. https://www.kanser.org/saglik/userfiles/TTOD_Covid19_Pandemisi_Danisma_Kurulunun_Kanser_Hastalarinda_Covid-19_Asilama_Onerileri.pdf  [cited 2024 November 1].
CR  - Durmuş A, Akbolat M, Amarat M. Turkish validity and reliability of COVID-19 Vaccine Literacy Scale. Cukurova Medical Journal, 2021;46(2):732-41.
CR  - Geniş B. Development of perception and attitude scales related with COVID-19 Pandemia. IEDSR Association, 2020;7(7):306-28.
CR  - NHS. What is the body mass index (BMI)? https://www.nhs.uk/common-health-questions/lifestyle/what-is-the-body-mass-index-bmi/ [cited 2024 April 7].
CR  - Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, et al. Influences on attitudes regarding potential COVID-19 vaccination in the United States. Vaccines, 2020;8(4):582.
CR  - Chun JY, Kim SI, Park EY, Park SY, Koh SJ, Cha Y, et al. Cancer patients’ willingness to take COVID-19 vaccination: A nationwide multicenter survey in Korea. Cancers (Basel), 2021;13(15): 3883.
CR  - Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: An overview. Hum Vaccin Immunother, 2013;9(8):1763-73.
CR  - Michel JP, Goldberg J. Education, healthy ageing and vaccine literacy. Journal of Nutrition, Health and Aging, 2021;25(5):698-701.
CR  - MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, Gellin B, et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine, 2015;33(34):4161-4.
CR  - Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007-2012. Vaccine, 2014;32(19):2150-9.
CR  - TÜİK. Housing Census, 2021. https://data.tuik.gov.tr/Bulten/Index?p=Nufus-ve-Konut-Sayimi-2021-45866 [cited 2024 March 15].
CR  - Biasio LR, Bonaccorsi G, Lorini C, Pecorelli S. Assessing COVID-19 vaccine literacy: a preliminary online survey. Hum Vaccin Immunother, 2021;17(5):1304-12.
CR  - Korkut S, Ülker T, Çidem A. Factors affecting COVID-19 vaccine literacy and attitudes towards COVID-19 vaccine. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 2022;11(3):1041-50.
UR  - https://dergipark.org.tr/tr/pub/turbietderg/issue//1688960
L1  - https://dergipark.org.tr/tr/download/article-file/4827112
ER  -